TNF and rheumatoid arthritis: In particular, we found that patients with progressive and, in the most cases, long-term RA remained with quantitative and qualitative Th1 systemic defects as well as a decreased population of functional CTLA-4+ Treg cells in PB despite TNF-alpha inhibitor (iTNF) treatment [25].